Various mechanisms of treatment resistance have been reported for glioblastoma (GBM)
and other tumors. Resistance to immunotherapy in GBM patients may be caused by …

Background: Inflammation plays an important role in tumorigenesis. Previous studies have
reported the prognostic value of several peripheral inflammatory markers in glioma patients …

Glioblastoma multiforme (GBM), WHO grade IV astrocytoma, is the most dramatic primary
brain cancer with a very poor prognosis due to inevitable disease recurrence. Less than …

Glioblastoma multiforme (GBM), the most common and deadly brain cancer, exemplifies the
paradigm that cancers grow with help from an immunosuppressive tumor microenvironment …

The brain tumor immune microenvironment (TIME) continuously evolves during glioma
progression, but only a limited view of a highly complex glioma associated immune …

Gliomas are intrinsic brain tumors that originate from glial cells. Glioblastoma (GBM) is the
most aggressive glioma type and resistant to immunotherapy, mainly due to its unique …

Background Glioblastoma (GBM) is a primary brain tumor with a dismal prognosis, often
resistant to immunotherapy and associated with immune suppression. This study aimed to …

Microglia and macrophages are the largest component of the inflammatory infiltrate in
glioblastoma (GBM). However, whether there are differences in their representation and …

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults, with a poor
prognosis, despite surgical resection combined with radio-and chemotherapy. The major …

Inflammation is a hallmark of cancers. The purpose of the present study was to evaluate the
prognostic potential of hematological inflammatory markers in glioblastoma multiforme …